The Small Angle X-ray Scattering (SAXS) market is segmented by Application into pharmaceuticals, materials science, biotechnology, and academic research. Pharmaceuticals dominate the segment, accounting for ~40% of the market, driven by demand for structural analysis of proteins and drug formulation. Materials science constitutes ~30%, focusing on polymer morphology and nanomaterial characterization. Biotechnology contributes ~20%, leveraging SAXS for biomolecular interactions, while academic research represents ~10%, prioritizing fundamental studies. These applications collectively define the SAXS market taxonomy, with pharmaceutical innovation and material science advancements being the primary growth drivers.